Literature DB >> 20740388

Defibrillation and resuscitation in a piglet model of pediatric ventricular fibrillation following AHA 2005 guidelines.

Zhengyu Zhou1, Yubin Wang, Huiying Zhou, Meng Huang, Huiting Liu, Chengtai Hsieh, Zhimou Xue.   

Abstract

OBJECTIVE: To evaluate the efficacy and safety of defibrillation on children according to AHA 2005 recommendations
METHODS: Pig resembles human in the chest configuration, anatomy and physiology of the cardiovascular and pulmonary systems. Piglets weighing 7.0 Kg ± 1.4kg, 14.0kg ± 2.8kg, 25.0kg ± 5.0kg respectively, which represented children 1 to 8 yr old were induced ventricular fibrillation (VF). An adult biphasic AED was used in conjunction with pediatric attenuating electrodes which could deliver 50-J shock for 2 min and two min of cardiopulmonary resuscitation (CPR) immediately followed it. If VF did not reverse, 70-J shock combined with CPR was used, and the protocol was repeated five times. If an organized cardiac rhythm with mean aortic pressure more than 60 mmHg persisted for an interval of 5 minutes, the animal was regarded as successfully resuscitated. If the AED recognized a "non-shockable" rhythm, CPR was also performed immediately for 2 min. The same resuscitation program was exercised on piglets of manual defibrillator group. Neurologic alertness score, hemodynamic and myocardial functions were evaluated, autopsy was routinely performed to document possible injuries.
RESULTS: In the AED group, 14 out of 15 animals, were successfully resuscitated, among them 11 piglets were resuscitated by 50-J defibrillation combined with cardiopulmonary resuscitation, and other three recovered to normal by 1 or 2 times of 70-J shocks and CPR. All animals in manual defibrillator group were successfully resuscitated by 50-J shocks and CPR. Left ventricular ejection fraction and fractional area change were reduced significantly during 3-4 hr post-resuscitation (P<0.05) and returned to baseline ranges at the end of 72 hr. There was no evidence of myocardial and pulmonary damage during autopsy, and neurologic recovery was also normal. Data of blood gas analysis, blood electrolytes and myocardial enzymes does not show any statistically significant difference (P> 0.05) in the groups. 50 J biphasic dose defibrillation combined with effective CPR, successfully terminated VF without adverse effects on myocardial function and survival in a piglet defibrillation model for young children 1 to 8 yr of age.
CONCLUSIONS: The new guidelines recommendation that one shock immediately followed by CPR is reasonable. Adults AED combined with pediatric electrodes is feasible to the diagnosis and treatment of pediatric VF model. But the user should not rely too much on AED's "automatic" function, but should accumulate and integrate his experience with AED technology.

Entities:  

Mesh:

Year:  2010        PMID: 20740388     DOI: 10.1007/s12098-010-0128-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

1.  Attenuating the defibrillation dosage decreases postresuscitation myocardial dysfunction in a swine model of pediatric ventricular fibrillation.

Authors:  Marc D Berg; Isabelle L Banville; Fred W Chapman; Robert G Walker; Mohammed A Gaballa; Ronald W Hilwig; Ricardo A Samson; Karl B Kern; Robert A Berg
Journal:  Pediatr Crit Care Med       Date:  2008-07       Impact factor: 3.624

2.  Fixed-energy biphasic waveform defibrillation in a pediatric model of cardiac arrest and resuscitation.

Authors:  Wanchun Tang; Max Harry Weil; Dawn Jorgenson; Kada Klouche; Carl Morgan; Ting Yu; Shijie Sun; David Snyder
Journal:  Crit Care Med       Date:  2002-12       Impact factor: 7.598

3.  Ventricular fibrillation in pediatric cardiac arrest.

Authors:  Brian T Smith; Tom D Rea; Mickey S Eisenberg
Journal:  Acad Emerg Med       Date:  2006-03-28       Impact factor: 3.451

4.  Pediatric defibrillation doses often fail to terminate prolonged out-of-hospital ventricular fibrillation in children.

Authors:  Marc D Berg; Ricardo A Samson; Robyn J Meyer; Lani L Clark; Terence D Valenzuela; Robert A Berg
Journal:  Resuscitation       Date:  2005-10       Impact factor: 5.262

5.  Body weight is a predictor of biphasic shock success for low energy transthoracic defibrillation.

Authors:  Yi Zhang; Craig B Clark; L Ray Davies; Gudjon Karlsson; M Bridget Zimmerman; Richard Kerber
Journal:  Resuscitation       Date:  2002-09       Impact factor: 5.262

6.  A prospective, population-based study of the epidemiology and outcome of out-of-hospital pediatric cardiopulmonary arrest.

Authors:  Kelly D Young; Marianne Gausche-Hill; Christian D McClung; Roger J Lewis
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

Review 7.  Ventricular fibrillation and the use of automated external defibrillators on children.

Authors:  David Markenson; Lee Pyles; Steve Neish
Journal:  Pediatrics       Date:  2007-10-29       Impact factor: 7.124

Review 8.  Cardiopulmonary resuscitation in children.

Authors:  Marc D Berg; Vinay M Nadkarni; Robert A Berg
Journal:  Curr Opin Crit Care       Date:  2008-06       Impact factor: 3.687

9.  Fully automatic external defibrillators in acute care: Clinicians' experiences and perceptions.

Authors:  Helen C Hancock; Alun Roebuck; Martyn Farrer; Steve Campbell
Journal:  Eur J Cardiovasc Nurs       Date:  2006-03-20       Impact factor: 3.908

  9 in total
  3 in total

1.  Neuronal cell death in neonatal hypoxia-ischemia.

Authors:  Frances J Northington; Raul Chavez-Valdez; Lee J Martin
Journal:  Ann Neurol       Date:  2011-05       Impact factor: 10.422

Review 2.  Effectiveness of alternative shock strategies for out-of-hospital cardiac arrest: A systematic review.

Authors:  Helen Pocock; Charles D Deakin; Ranjit Lall; Christopher M Smith; Gavin D Perkins
Journal:  Resusc Plus       Date:  2022-05-11

3.  Pediatric defibrillation shocks alone do not cause heart damage in a porcine model.

Authors:  Ben McCartney; Adam Harvey; Amy Kernaghan; Sara Morais; Olibhéar McAlister; Paul Crawford; Pardis Biglarbeigi; Raymond Bond; Dewar Finlay; David McEneaney
Journal:  Resusc Plus       Date:  2022-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.